期刊文献+

胰岛素受体底物-1基因rs1078533单核苷酸多态性与2型糖尿病合并冠心病患者氯吡格雷抵抗的相关性研究 被引量:4

Relation between rs1078533 polymorphism of IRS-1 gene and clopidogrel resistance in patients with type 2 diabetes mellitus accompanying coronary artery disease
下载PDF
导出
摘要 目的探讨胰岛素受体底物-1(insulin receptor substrate-1,IRS-1)基因rs1078533单核苷酸多态性与2型糖尿病合并冠心病患者氯吡格雷抵抗(clopidogrel resistance,CR)发生的相关性。方法入选2012年4月-2013年4月沈阳军区总医院2型糖尿病合并冠心病住院患者325例,采用光学比浊法测定20μmol/L二磷酸腺苷(adenosine diphosphate,ADP)诱导的残余血小板聚集率(residual platelet agglutination,RPA),当RPA≥70%时定义为CR。所有入选患者根据RPA分为CR组(n=142)和非氯吡格雷抵抗(NCR)组(n=183)。采用聚合酶链式反应结合直接测序法测定IRS-1基因rs1078533位点在CR组和NCR组的基因型及等位基因分布频率。结果 IRS-1基因rs1078533多态位点在CR组和NCR组基因型分布频率符合Hardy-Weinberg平衡。三种基因型(AA、AC和CC)在两组的分布频率分别为1.4%、16.8%、81.8%和1.6%、19.8%、78.6%。基因型(AA、AC和CC)及等位基因(A和C)分布频率在CR组和NCR组间均无统计学差异(P=0.786,P=0.524)。Logistic回归分析校正性别、年龄、体质量指数、吸烟和高血压等冠心病和糖尿病易患因素后,IRS-1基因rs1078533单核苷酸多态性仍与2型糖尿病合并冠心病患者CR的发生无相关性。结论 IRS-1基因rs1078533单核苷酸多态性与2型糖尿病合并冠心病患者CR的发生无相关性。 Objective To study the relation between rs1078533 polymorphism of IRS-1 gene and clopidogrel resistance (CR) in Chinese patients with type 2 diabetes mellitus (DM) accompanying coronary artery disease (CAD). Methods Three hundred and twenty-five patients with type 2 DM accompanying CAD admitted to General Hospital of Shenyang Military Area Command from April 2012 to April 2013 were enrolled in this study. Their residual platelet aggregation rate (RPA) induced by 20 μmol/L adenosine diphosphate (ADP) was measured by optical nephelometry. The CR was defined when the RPA was ≥ 70%. The patients were divided into CR group (n=142) and non-CR group (n=183) according to their RPA. The genotypes and allele frequencies at rs 1078533 of IRS-1 gene in two groups were detected by PCR and pyrophosphate sequencing, respectively. Results The genotype frequencies at rs1078533 of IRS-1 gene conformed to the Hardy-Weinberg equilibrium in two groups. The frequency of genotypes (AA, AC and CC) was 1.4%, 16.8%, 81.8%, respectively, in CR group and 1.6%, 19.8%, 78.6%, respectively, in non-CR group. No significant difference was observed in genotypes and allele frequencies between the two groups (P = 0.786 and P = 0.524). Logistic regression analysis revealed that the rs1078533 polymorphism was not related with the CR after adjustment of risk factors including age, gender, BMI, smoking and hypertension in patients with type 2 DM accompanying CAD. Conclusion The rs1078533 polymorphism of IRS- 1 gene is not related with the CR in patients with type 2 DM accompanying CAD.
出处 《解放军医学院学报》 CAS 2014年第1期74-77,共4页 Academic Journal of Chinese PLA Medical School
基金 国家十二五科技支撑课题(2011BAI11B07) 军队临床高新技术重大项目(2012GXJS001)~~
关键词 氯吡格雷抵抗 胰岛素受体底物-1 2型糖尿病合并冠心病 单核苷酸多态性 clopidogrel resistance insulin receptor substrate 1 type 2 diabetes mellitus complicated by coronary artery disease single nucleotide polymorphism
  • 相关文献

参考文献16

  • 1Anderson JL,Adams CD,Antman EM. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].{H}CIRCULATION,2013,(23):e663-e828.
  • 2Torabi A,Cleland JG,Khan NK. The timing of development and subsequent clinical course of heart failure after a myocardial infarction[J].{H}EUROPEAN HEART JOURNAL,2008,(07):859-870.
  • 3Bhatt DL,Fox KA,Hacke W. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events[J].{H}New England Journal of Medicine,2006,(16):1706-1717.
  • 4Price MJ,Berger PB,Teirstein PS. Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention:the GRAVITAS randomized trial[J].{H}JAMA:the Journal of the American Medical Association,2011,(11):1097-1105.
  • 5Angiolillo D J,Fernandez-Ortiz A,Bernardo E. Variability in individual responsiveness to clopidogrel:clinical implications,management,and future perspectives[J].{H}Journal of the America College of Cardiology,2007,(14):1505-1516.
  • 6Geisler T,Anders N,Paterok M. Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation[J].{H}DIABETES CARE,2007,(02):372-374.
  • 7Angiolillo DJ. Antiplatelet therapy in diabetes:efficacy and limitations of current treatment strategies and future directions[J].{H}DIABETES CARE,2009,(04):531-540.
  • 8Angiolillo D J,Bemardo E,Zanoni M. Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease[J].{H}Journal of the America College of Cardiology,2011,(01):30-39.
  • 9Ferreira IA,Mocking AI,Feijge MA. Platelet inhibition by insulin is absent in type 2 diabetes mellitus[J].{H}Arteriosclerosis Thrombosis and Vasoular Biology,2006,(02):417-422.
  • 10肖淳纯,任安.2型糖尿病与血小板P2Y12受体[J].国际病理科学与临床杂志,2008,28(2):153-156. 被引量:1

二级参考文献21

  • 1Matsuno H, Tokuda H, Ishisaki A,et al. P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes [ J ]. Clin Endocfinol Metab, 2005,90 ( 2 ) : 920-927.
  • 2Dorsam RT, Kunapuli SP. Central role of the P2Y12 receptor in platelet activation, [ J]. Clin Invest, 2004,113 (3) :340-345.
  • 3Remijn JA, Wu YP, Jeninga EH, et al. Role of ADP receptor P2Y12 in platelet adhesion and thrombus formation in flowing blood [ J]. Arterioscler Thromb Vasc Biol, 2002,22 (4) :686-691.
  • 4Ferreira IA, Eybrechts KL, Mocking AI, et al. IRS-1 mediates inhibition of Ca^2+ mobilization by insulin via the Inhibitory G-protein Gi ^* [J]. J Biol Chem, 2004,279(5) :3254-3264.
  • 5Ferreira IA, Mocking AI, Feljge MA, et al. Platelet inhibition by insulin is absent in type 2 diabetes mellitus [ J ]. Arterioscler Thromb Vasc Biol, 2006,26 ( 2 ) : 417-422.
  • 6Trovati M, Anfossi G, Massucco P, et al. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3 ' , 5 '-cyclic monophosphate and adenosine-3 ' , 5 ' -cyclic monophosphate [ J ]. Diabetes, 1997,46 (5) :742-749.
  • 7Federici M, Pandolfi A, De Filippis EA, et al. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells[ J]. Circulation,2004,109 (3) : 399-405.
  • 8Sesti G, Federici M, Hribal ML,et al. Defects of the insulin receptor substrate ( IRS ) system in human metabolic disorders [ J ]. FASEB,2001,15(12) :2099-2111.
  • 9Marini MA, Frontoni S, Mineo D, et al. The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients [ J ]. Clin Endocrinol Metab, 2003,88(7 ) :3368-3371.
  • 10Mateos-Trigos G, Evans RJ, Heath MF. Effects of P2Y ( 1 ) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets : comparison with human platelets [ J ]. Platelets, 2002,13(5-6) :285-292.

同被引文献42

  • 1罗丹,鄢盛恺,程歆琦,宋耀虹.2型糖尿病合并冠心病患者的同型半胱氨酸水平及代谢关键酶基因多态性特点[J].卫生研究,2009,38(1):39-42. 被引量:10
  • 2Biessels GJ, Strachan MW, Visseren F, et al. Dementia and cognitive decline in type 2 diabetes and prediabetic stages., towards targeted interventions [J]. Lancet Diabe- tes Endocrinol,2014,2(3) :246-255.
  • 3Malmgren S, Spegel P, Danielsson AP, et al. Coordinate chan- ges in histone modifications, mRNA levels, and metabolite profiles in clonal INS-1 832/13 13-cells accompany functional adaptations to lipotoxicity[J]. J Biol Chem, 2013,288 (17) : 11973-11987.
  • 4Carobbio S, Hagen RM, Lelliott C J, et al. Adaptive chan- ges of the Insigl/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity [J]. Diabetes, 2013,62 (11) : 3697-3708.
  • 5Roberts LD, Koulman A, Griffin JL. Towards metabolic biomarkers of insulin resistance and type 2 diabetes:pro- gress from the metabolome[J]. Lancet Diabetes Endoeri- noi,2014,2(1) : 65-75.
  • 6Bermudez VJ, Rojas E, Toledo A, et al. Single-nucleotide polymorphisms in adiponectin, AdipoR1, and AdipoR2 genes:insulin resistance and type 2 diabetes mellitus can- didate genes[J]. Am J Ther,2013,20(4) :414-421.
  • 7Tsai YC, Leichner GS, Pearce MM, et al. Differential reg- ulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system[J]. Mol Biol Cell, 2012, 23(23) :4484-4494.
  • 8Price M J, Berger P B, Teirstein P S, et al.Standard-vs high- dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial[J].JAMA, 2011, 305 ( 11 ) : 1097-1105.
  • 9Ferreiro J L, Gomez-Hospital J A, Angiolillo D J.Plate|et abnormalities in diabetes mellitus[J].Diab Vase Dis Res, 2010, 7 ( 4 ) : 251-259.
  • 10Hwang S L, Jeong Y T, Hye Yang 1, et al.Pinusolide improves high glucose-induced insulin resistance via activation of AMP-activated pmtein kinase[J].Biochem Biophys Res Commun, 2013, 437 ( 3 ) : 374-379.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部